Evaluation of Physical and Functional Status in Patients With COVID-19 in Long Term
NCT ID: NCT04836767
Last Updated: 2022-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2021-02-16
2022-02-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physical Fitness in Young Healthy Adults After COVID-19 Infection
NCT05133622
Investigation of the Muscle Oxygenation in Patients With Post COVID-19 Syndrome
NCT05957575
The Investigation Of Exercise Capacity And Exercise-Induced Fatigue in Young Adults Who Survived From Coronavirus
NCT04864132
Effect of Physical Therapy Exercises on Cardiorespiratory Fitness Level in COVID19 Patients After Recovery.
NCT04445376
Musculoskeletal Problems and Endurance in Healthcare Professionals With and Without COVID-19
NCT05075018
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
3\. Materials and Methods of the Research: 3.1. The place of the study: Cardiopulmonary Rehabilitation Unit of Hacettepe University Faculty of Physical Therapy and Rehabilitation and Hacettepe University Faculty of Medicine Department of General Internal Medicine
3.2. Time of the study: It is planned to collect data and write the study between February 2021 and February 2022.
3.3. Research population, sample, research group:
The population of the study is individuals who have passed the diagnosis of COVID-19 for at least 12 weeks and healthy individuals who have not had COVID-19.
The sample of the study is individuals in the long-term after the diagnosis of COVID-19 at least 12 weeks after the diagnosis of COVID-19 in Hacettepe University Adult Hospital who meet the inclusion criteria and volunteer to participate in the study, and healthy individuals who have not had COVID-19.
Study Design:
Individuals meeting the inclusion criteria will be included in the study. The study will be conducted with people between the ages of 18-65, whose education level is at least primary school, and whose local language is Turkish. A total of 40 participants, 20 healthy without COVID-19, and 20 with at least 12 weeks past the diagnosis of COVID-19, will be included in the study. The guidance of the participants will be provided by the relevant physicians of the General Internal Medicine Unit of Hacettepe University Internal Diseases Department.
In accordance with the COVID-19 pandemic precautions, social distance rules will be followed in the tests to be carried out with individuals, care will be taken to use masks, and the materials to be used in tests and measurements will be disinfected before and after use.
COVID-19 Group Inclusion Criteria
* Having been diagnosed with COVID-19 at least 12 weeks ago,
* Being literate,
* Being in the age range of 18-65,
* Volunteering to participate in research,
* To be clinically stable, to be under control if any accompanying comorbid conditions (such as hypertension, diabetes),
* Not having any orthopedic and neurological problems that might interfere with evaluating peripheral muscle strength, balance and exercise capacity.
COVID-19 Group Exclusion Criteria
* Those with an ICU hospitalization history due to the diagnosis of COVID-19,
* Recent myocardial infarction and pulmonary embolism.
* Having accompanying chronic diseases,
* Those who have any orthopedic or neurological disorders that will prevent walking,
* Another COVID-19 PCR Test positivity in the last 12 weeks,
* Not being able to cooperate and adapt to exercise test due to neurological influences such as cerebrovascular disease or psychiatric disorders,
Healthy Group Inclusion Criteria
* Not having COVID-19,
* Being literate,
* Being in the age range of 18-65,
* Volunteering to participate in research.
The Criteria for Not Including the Healthy Group in the Study
* Those who have any orthopedic or neuromuscular disorders that will prevent walking,
* Having any chronic illness or psychiatric conditions or mental afflictions that may interfere with cooperation or compliance with exercise tests.
Individuals participating in the study will be informed verbally and in writing about the study protocol and informed consent form will be obtained.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
people with a history of COVID-19
COVID-19 Group Inclusion Criteria
* Having been diagnosed with COVID-19 at least 12 weeks ago,
* Being literate,
* Being in the age range of 18-65,
* Volunteering to participate in research,
* To be clinically stable, to be under control if any accompanying comorbid conditions (such as hypertension, diabetes),
* Not having any orthopedic and neurological problems that might interfere with evaluating peripheral muscle strength, balance and exercise capacity.
COVID-19 Group Exclusion Criteria
* Those with an ICU hospitalization history due to the diagnosis of COVID-19,
* Recent myocardial infarction and pulmonary embolism.
* Having accompanying chronic diseases,
* Those who have any orthopedic or neurological disorders that will prevent walking,
* Another COVID-19 PCR Test positivity in the last 12 weeks,
* Not being able to cooperate and adapt to exercise test due to neurological influences such as cerebrovascular disease or psychiatric disorders,
No interventions assigned to this group
healthy people
Healthy Group Inclusion Criteria
* Not having COVID-19,
* Being literate,
* Being in the age range of 18-65,
* Volunteering to participate in research. The Criteria for Not Including the Healthy Group in the Study
* Those who have any orthopedic or neuromuscular disorders that will prevent walking,
* Having any chronic illness or psychiatric conditions or mental afflictions that may interfere with cooperation or compliance with exercise tests.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being literate,
* Being in the age range of 18-65,
* Volunteering to participate in research,
* To be clinically stable, to be under control if any accompanying comorbid conditions (such as hypertension, diabetes),
* Not having any orthopedic and neurological problems that might interfere with evaluating peripheral muscle strength, balance and exercise capacity.
* Not having COVID-19,
* Being literate,
* Being in the age range of 18-65,
* Volunteering to participate in research. The Criteria for Not Including the Healthy Group in the Study
* Those who have any orthopedic or neuromuscular disorders that will prevent walking,
* Having any chronic illness or psychiatric conditions or mental afflictions that may interfere with cooperation or compliance with exercise tests.
Exclusion Criteria
* Having accompanying chronic diseases,
* Those who have any orthopedic or neurological disorders that will prevent walking,
* Another COVID-19 PCR Test positivity in the last 12 weeks,
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hacettepe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ebru Calik Kutukcu
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gülay Sain-Guven, Professor
Role: STUDY_DIRECTOR
Hacettepe University, Faculty of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hacettepe University
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Barker-Davies RM, O'Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S, Ellis H, Goodall D, Gough M, Lewis S, Norman J, Papadopoulou T, Roscoe D, Sherwood D, Turner P, Walker T, Mistlin A, Phillip R, Nicol AM, Bennett AN, Bahadur S. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020 Aug;54(16):949-959. doi: 10.1136/bjsports-2020-102596. Epub 2020 May 31.
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, Tai Y, Bai C, Gao T, Song J, Xia P, Dong J, Zhao J, Wang FS. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18. No abstract available.
Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020 May;19(5):383-384. doi: 10.1016/S1474-4422(20)30109-5. Epub 2020 Apr 1. No abstract available.
Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003. Chinese.
Belli S, Balbi B, Prince I, Cattaneo D, Masocco F, Zaccaria S, Bertalli L, Cattini F, Lomazzo A, Dal Negro F, Giardini M, Franssen FME, Janssen DJA, Spruit MA. Low physical functioning and impaired performance of activities of daily life in COVID-19 patients who survived hospitalisation. Eur Respir J. 2020 Oct 15;56(4):2002096. doi: 10.1183/13993003.02096-2020. Print 2020 Oct.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GO21-178
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.